EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study

Levy T S Domingos iD, Daniel C de Moraes, Mário F C Santos iD, José A R Curvelo, Brayan Bayona-Pacheco iD, Edgar A Marquez iD, Anthony W B Martinez, Roberto G S Berlinck, Antonio Ferreira-Pereira iD

Marine Drugs · 2024

DOI: 10.3390/md22110502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Levy T S Domingos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Bioquímica Microbiana, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Universidade Federal do R…. Hauptthemen laut MEDLINE: Biofilms, Fluconazole, Candida albicans, Drug Resistance, Fungal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo State Research Foundation, Brazilian National Council for Scientific and Technological Development, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brazil.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous Candida species are responsible for fungal infections; however, Candida albicans stands out among the others. Treatment with fluconazole is often ineffective due to the resistance phenotype mediated by transmembrane transporters and/or biofilm formation, mechanisms of resistance commonly found in C. albicans strains. A previous study by our group demonstrated that batzelladine D can inhibit the Pdr5p transporter in Saccharomyces cerevisiae. In the present study, our aim was to investigate the efficacy of batzelladine D in inhibiting the main efflux pumps of Candida albicans, CaCdr1p and CaCdr2p, as well as to evaluate the effect of the compound on C. albicans biofilm. Assays were conducted using a clinical isolate of Candida albicans expressing both transporters. Additionally, to allow the study of each transporter, S. cerevisiae mutant strains overexpressing CaCdr1p or CaCdr2p were used. Batzelladine D was able to reverse the fluconazole resistance phenotype by acting on both transporters. The compound synergistically improved the effect of fluconazole against the clinical isolate when tested in the Caenorhabditis elegans animal model. Moreover, the compound disrupted the preformed biofilm. Based on the obtained data, the continuation of batzelladine D studies as a potential new antifungal agent and/or chemosensitizer in Candida albicans infections can be suggested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsFluconazoleCandida albicansDrug Resistance, FungalAntifungal AgentsCaenorhabditis elegansSaccharomyces cerevisiaeAnimalsMembrane Transport ProteinsBiological ProductsMicrobial Sensitivity TestsPhenotypeComputer SimulationFungal Proteins

Stichwörter der Autor:innen

Caenorhabditis elegansCandida albicansanti-biofilmbatzelladine Dfluconazole resistancemarine natural productsmarine spongesmultidrug transporters

Substanzen

FluconazoleAntifungal AgentsMembrane Transport ProteinsBiological ProductsFungal Proteins

Autor:innen und Institutionen

  • Laboratório de Bioquímica Microbiana, Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-590, RJ, Brazil.
  • Instituto de Química de São Carlos, Universidade de São Paulo, CP 780, São Carlos 13560-970, SP, Brazil.
  • Departamento de Medicina, División Ciencias de la Salud, Universidad del Norte, km 5, Vía Puerto Colombia, Área Metropolitana de Barranquilla, Barranquilla 081007, Colombia.
  • Departamento de Química y Biologia, Facultad de Ciencias Básicas, Universidad del Norte, km 5, Vía Puerto Colombia, Área Metropolitana de Barranquilla, Barranquilla 081007, Colombia.

ORCID-Profile: Levy T S Domingos, Mário F C Santos, Brayan Bayona-Pacheco, Edgar A Marquez, Antonio Ferreira-Pereira

Förderung

  • São Paulo State Research Foundation
  • Brazilian National Council for Scientific and Technological Development
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brazil
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Domingos, L. T. S., de Moraes, D. C., Santos, M. F. C., Curvelo, J. A. R., Bayona-Pacheco, B., Marquez, E. A., Martinez, A. W. B., Berlinck, R. G. S., & Ferreira-Pereira, A. (2024). Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study. Marine Drugs. https://doi.org/10.3390/md22110502

Vancouver

Domingos LTS, de Moraes DC, Santos MFC, Curvelo JAR, Bayona-Pacheco B, Marquez EA, et al. Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study. Marine Drugs. 2024. doi:10.3390/md22110502

BibTeX
@article{Domingos2024,
  author = {Domingos, Levy T S and de Moraes, Daniel C and Santos, Mário F C and Curvelo, José A R and Bayona-Pacheco, Brayan and Marquez, Edgar A and Martinez, Anthony W B and Berlinck, Roberto G S and Ferreira-Pereira, Antonio},
  title = {Batzelladine D, a Marine Natural Product, Reverses the Fluconazole Resistance Phenotype Mediated by Transmembrane Transporters in Candida albicans and Interferes with Its Biofilm: An In Vitro and In Silico Study},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22110502}
}
Kostenlos starten →